• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用异烟肼-咖啡酸和香草酸共晶提高抗结核固定剂量组合药物的稳定性。

Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.

机构信息

School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli, Central University PO, Hyderabad 500 046, India.

School of Chemistry, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli, Central University PO, Hyderabad 500 046, India; CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411 008, India.

出版信息

J Pharm Sci. 2018 Jun;107(6):1667-1679. doi: 10.1016/j.xphs.2018.02.014. Epub 2018 Feb 17.

DOI:10.1016/j.xphs.2018.02.014
PMID:29462633
Abstract

The classic fixed-dose combination (FDC) of 4 tuberculosis drugs, namely rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA), and ethambutol dihydrochloride (EDH) has the twin issues of physical stability and RIF cross-reaction in the 4-FDC. The major reason for these quality issues is the interaction between RIF and INH to yield isonicotinyl hydrazone in drug tablets. Pharmaceutical cocrystals of INH with caffeic acid (CFA) (PZA + EDH + RIF + INH-CFA cocrystal) and vanillic acid (VLA) (PZA + EDH + RIF + INH-VLA cocrystal) are able to stabilize the FDC formulation compared with the reference batch (PZA + EDH + RIF + INH). Stability studies under accelerated humidity and temperature stress conditions of 40°C and 75% relative humidity showed that the physical stability of the cocrystal formulation was superior by powder X-ray diffraction and scanning electron microscopy analysis, and chemical purity was analyzed by high-performance liquid chromatography. Changes in the composition and structure were monitored on samples drawn at 7, 15, 22, and 30 days of storage. FDC-INH-CFA cocrystal batch exhibited greater stability compared with FDC-INH-VLA cocrystal and FDC reference drug batches. The superior stability of INH-CFA cocrystal is attributed to the presence of stronger hydrogen bonds and cyclic O-H⋯O synthon in the crystal structure.

摘要

经典的 4 种结核病药物固定剂量组合(FDC),即利福平(RIF)、异烟肼(INH)、吡嗪酰胺(PZA)和盐酸乙胺丁醇(EDH),存在物理稳定性和 4-FDC 中 RIF 交叉反应这两个问题。这些质量问题的主要原因是 RIF 和 INH 之间的相互作用,导致药物片剂中生成异烟酰肼。INH 与咖啡酸(CFA)(PZA+EDH+RIF+INH-CFA 共晶)和香草酸(VLA)(PZA+EDH+RIF+INH-VLA 共晶)的药物共晶能够稳定 FDC 配方,与参比批次(PZA+EDH+RIF+INH)相比。在 40°C 和 75%相对湿度的加速湿度和温度应激条件下进行的稳定性研究表明,通过粉末 X 射线衍射和扫描电子显微镜分析,共晶配方的物理稳定性更好,通过高效液相色谱法分析化学纯度。在储存 7、15、22 和 30 天的样品上监测组成和结构的变化。与 FDC-INH-VLA 共晶和 FDC 参比药物批次相比,FDC-INH-CFA 共晶批次表现出更好的稳定性。INH-CFA 共晶的稳定性更好,是由于其晶体结构中存在更强的氢键和环状 O-H⋯O 缩合键。

相似文献

1
Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.使用异烟肼-咖啡酸和香草酸共晶提高抗结核固定剂量组合药物的稳定性。
J Pharm Sci. 2018 Jun;107(6):1667-1679. doi: 10.1016/j.xphs.2018.02.014. Epub 2018 Feb 17.
2
A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.四种药物固定剂量组合抗结核产品的初步稳定性研究。
Int J Tuberc Lung Dis. 2003 Mar;7(3):298-303.
3
Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.对吡嗪酰胺和乙胺丁醇在抗结核固定剂量复方制剂中催化利福平与异烟肼之间反应的机理解释。
J Pharm Biomed Anal. 2005 Oct 4;39(5):892-9. doi: 10.1016/j.jpba.2005.05.015. Epub 2005 Jun 22.
4
Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.异烟肼、利福平及吡嗪酰胺在用于儿童结核病治疗的混悬液中的稳定性。
Pediatr Infect Dis J. 1991 Nov;10(11):827-31. doi: 10.1097/00006454-199111000-00007.
5
Assessing Polymorphic Purity of Rifampicin in Double and Triple-Drug Fixed-Dose Combination Products.评估双药和三药固定剂量复方制剂中利福平的多态纯度。
J Pharm Sci. 2024 Apr;113(4):930-936. doi: 10.1016/j.xphs.2023.09.023. Epub 2023 Sep 30.
6
Anti-tuberculosis 4FDC tablets--mystery to chemistry.抗结核四联固定剂量复合制剂片剂——化学之谜
Int J Tuberc Lung Dis. 2003 Mar;7(3):205-6.
7
Compatibility Between Four Anti-TB Drugs and Tablet Excipients Determined By Microcalorimetry.微量热法测定四种抗结核药物与片剂辅料的相容性
Pharmazie. 2019 Jun 1;74(6):350-351. doi: 10.1691/ph.2019.8189.
8
Tackling quantitative polymorphic analysis through fixed-dose combination tablets production. Pyrazinamide polymorphic assessment.通过生产固定剂量复方片剂解决定量多晶型分析问题。吡嗪酰胺多晶型评估。
J Pharm Biomed Anal. 2021 Feb 5;194:113786. doi: 10.1016/j.jpba.2020.113786. Epub 2020 Nov 23.
9
Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.固定剂量抗结核复方制剂
Int J Tuberc Lung Dis. 2003 Mar;7(3):289-97.
10
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.异烟肼对利福平-吡嗪酰胺联合用药在小鼠结核病模型中活性的矛盾效应。
Antimicrob Agents Chemother. 2009 Oct;53(10):4178-84. doi: 10.1128/AAC.00830-09. Epub 2009 Jul 20.

引用本文的文献

1
New Ionic Liquid Forms of Antituberculosis Drug Combinations for Optimized Stability and Dissolution.用于优化稳定性和溶解性的新型抗结核药物组合离子液体形式
AAPS PharmSciTech. 2025 Jan 8;26(1):27. doi: 10.1208/s12249-024-03023-1.
2
Quality of antiretroviral, antimalarial and antituberculosis medicines in Zambia: Findings of routine post-marketing surveillance.赞比亚抗逆转录病毒药物、抗疟疾药物和抗结核药物的质量:上市后常规监测结果
J Med Access. 2024 Jul 25;8:27550834241266755. doi: 10.1177/27550834241266755. eCollection 2024 Jan-Dec.
3
A pharmaceutical monitoring system to assess the quality of antituberculosis drug products used in Mauritania.
一个用于评估毛里塔尼亚抗结核药品质量的药品监测系统。
PLoS One. 2023 Mar 16;18(3):e0282023. doi: 10.1371/journal.pone.0282023. eCollection 2023.
4
Mitigating Drug Stability Challenges Through Cocrystallization.通过共结晶减轻药物稳定性挑战。
AAPS PharmSciTech. 2023 Feb 9;24(2):62. doi: 10.1208/s12249-023-02522-x.
5
Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis.通过 DOE 和 MLR 开发和优化一种新的 UPLC-UV/MS 方法,用于检测治疗结核病的劣药产品。
Molecules. 2022 Oct 21;27(20):7141. doi: 10.3390/molecules27207141.
6
Design of Ascorbic Acid Eutectic Mixtures With Sugars to Inhibit Oxidative Degradation.用于抑制氧化降解的抗坏血酸与糖类共晶混合物的设计
Front Chem. 2022 May 9;10:754269. doi: 10.3389/fchem.2022.754269. eCollection 2022.
7
Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid-Sulfamethazine Cocrystals.纳米级4-氨基水杨酸-磺胺二甲嘧啶共晶体的合成与表征
Pharmaceutics. 2021 Feb 19;13(2):277. doi: 10.3390/pharmaceutics13020277.
8
Mechanochemical Synthesis and Physicochemical Characterization of Isoniazid and Pyrazinamide Co-crystals With Glutaric Acid.异烟肼和吡嗪酰胺与戊二酸共晶体的机械化学合成及物理化学表征
Front Chem. 2020 Nov 16;8:595908. doi: 10.3389/fchem.2020.595908. eCollection 2020.
9
Organic Salts Based on Isoniazid Drug: Synthesis, Bioavailability and Cytotoxicity Studies.基于异烟肼药物的有机盐:合成、生物利用度及细胞毒性研究
Pharmaceutics. 2020 Oct 10;12(10):952. doi: 10.3390/pharmaceutics12100952.
10
Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics.使用羟丙基-β-环糊精治疗小儿结核病的异烟肼和利福平口服溶液稳定性研究
Pharmaceutics. 2020 Feb 24;12(2):195. doi: 10.3390/pharmaceutics12020195.